Biofil Chemicals & Pharmaceuticals Ltd

NSE: BIOFILCHEM · BSE: 524396 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹30.30
Market cap: ₹49.31 Cr
Revenue (annual): ₹28.40 Cr
Net profit (annual): ₹2.79 Cr
P/E (TTM): 101.9×Sector 47.4×
Promoter holding: 46.79%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Management Change 2 Board Meeting Date 2 Annual General Meeting 2 Other Announcement 1 Legal & Regulatory 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

11 Aug 2026 18:09 IST BSE

Financial Results

Biofil Chemicals & Pharmaceuticals Q1 FY27 Results: Net Profit ₹0.1 Cr, Down 95.8% YoY

Biofil Chemicals & Pharmaceuticals Ltd reported revenue from operations of ₹12.4 Cr (+93.8% YoY) and net profit of ₹0.1 Cr (-95.8% YoY) for Q1 FY27.

Key figure: Net profit ₹0.1 Cr · -95.8% YoY

Open full results → Read the filing ↗

30 May 2026 18:52 IST BSE

Financial Results

Biofil Chemicals & Pharmaceuticals Q4 FY26 Results: Net Profit ₹0.2 Cr, Up 0.0% YoY

Biofil Chemicals & Pharmaceuticals Ltd reported revenue from operations of ₹7.6 Cr (-9.5% YoY) and net profit of ₹0.2 Cr (+0.0% YoY) for Q4 FY26.

Key figure: Net profit ₹0.2 Cr · +0.0% YoY

Open full results → Read the filing ↗

30 May 2026 18:51 IST BSE

Financial Results

Biofil Chemicals & Pharmaceuticals Financial Results

Biofil Chemicals reported annual revenue of ₹28.40 Crore for FY26. The Board approved audited results with an unmodified auditor opinion during its May 2026 meeting.

Value: ₹28.40 Cr

Read the filing ↗